Advertisement: HCR Hewitsons mid banner
Advertisement: Excalibur Healthcare mid banner
Advertisement: Wild Knight Vodka
Advertisement: Mogrify mid banner
Barr Ellison Solicitors – commercial property
Advertisement: CJBS mid banner
Advertisement: Cambridge Network mid banner
Advertisement: TTP
Advertisement: RSM mid banner
ARM Innovation Hub
Advertisement: S-Tech mid banner 3
Advertisement: Kao Data Centre mid banner
Advertisement: partnersand mid banner
Advertisement: Simpsons Creative
Mid banner advertisement: BDO
Advertisement: EBCam mid banner
2 January, 2019 - 12:10 By Kate Sweeney

MedTech Accelerator injects £430k into pioneering projects

Medtech Accelerator, the medical technology financial scheme that supports NHS innovators through the early stages of product development, has made awards of more than £430,000 to four pioneering projects in the East of England.

TumourVue Ltd, a disruptive medical imaging device for cancer surgery, received £125k; a heat activated adhesive polymerisation system for meshed groin hernia and abdominal wall repairs from Andrew Hindmarsh  (Cambridge University Hospitals NHS Foundation Trust) was awarded £100k; a Dissection Plane Splayer device from Amit Agrawal – also Cambridge University Hospital NHS Foundation Trust – wins £95,205; a project helping children with glue ear to hear, steered by Tamsin Brown of Cambridgeshire Community Services NHS Trust, earns £109,000.

TumourVue Ltd is the brainwave of Gita Moghaddam  in partnership with Cambridge University Hospital NHS Foundation Trust & University of Cambridge.

Retrospective studies indicate that those undergoing cancer surgery carry a lifelong risk of local reccurrence of cancer. Therefore, determining clear excision margins during surgery is essential to reducing the risk of reccurrence. 

TumourVue Ltd, a newly formed start up, are developing a clip-on device that can be added to a pair of safety or prescription glasses worn by the surgeon. Thus allowing a colour-coded image to be superimposed onto the surgeon’s eye as an assistive technology to facilitate operations and provide precise, objective tumour margin detection during surgery.. The award from the Medtech Accelerator will be used to develop a working prototype of the device and develop their business plan.

The heat activated adhesive polymerisation system for meshed groin hernia and abdominal wall repairs addresses a key area of unmet medical need.

Abdominal wall and groin hernias are a common surgical problem and the goal standard of care is the to place a surgical mesh at the weak spot where the hernia came through, to strengthen it. 

Chronic pain can occur due to the mechanical fixation methods used to secure the mesh during surgery including sutures and permanent/absorbable tacks. 

This innovation project is developing a novel, heat activated, adhesive polymerisation system (‘glue’) that could be used for meshed groin hernia and abdominal wall repairs. 

This easy-to-use solution will allow better manoeuvring and positioning and bond strength without recourse to additional fixation methods currently required during the repair. 

Funding from the Medtech Accelerator will be used to further develop the adhesive polymer formulation and early testing to then ready this technology for commercialisation.

Medtech Accelerator is a joint venture led by innovation hub Health Enterprise East (HEE) in partnership with the New Anglia Local Enterprise Partnerships (LEP), Cambridgeshire & Peterborough Combined Authority, the Eastern Academic Health Science Network (AHSN) and Essex County Council.

This latest round of funding brings the total number of awards granted by Medtech Accelerator to 11 since its launch in 2016 with over £1 million of funding committed.

Chris Dashper from New Anglia Local Enterprise Partnership, said: “Technological innovation has been singled out by policymakers as playing a vital role in addressing some of the key challenges faced by the NHS, yet all too often innovations and great ideas fall at the first hurdle and fail to get to market. 

“Thanks to the Medtech Accelerator, emerging medtech innovations can receive the funding and technical guidance they need to make it through the precarious proof of concept phase.”

Newsletter Subscription

Stay informed of the latest news and features